Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome

Endocrine Reviews - Tập 21 Số 6 - Trang 697-738 - 2000
B L Wajchenberg1
1Endocrine Service, Hospital das Clinicas of The University of São Paulo Medical School, São Paulo, SP, Brazil

Tóm tắt

Từ khóa


Tài liệu tham khảo

Feinleib, 1985, Epidemiology of obesity in relation to health hazards., Ann Intern Med, 103, 1019, 10.7326/0003-4819-103-6-1019

Kannel, 1985, Lipids, diabetes and coronary heart disease: insights from the Framingham Study., Am Heart J, 110, 1100, 10.1016/0002-8703(85)90224-8

Keys, 1980, Overweight, obesity, coronary heart disease and mortality., Nutr Rev, 38, 297, 10.1111/j.1753-4887.1980.tb05967.x

Mann, 1974, The influence of obesity and health: part 2., N Engl J Med, 291, 226, 10.1056/NEJM197408012910504

Larsson, 1991, Obesity, fat distribution and cardiovascular disease., Int J Obesity, 15, 53

Vague, 1947, La differénciation sexuelle, facteur determinant des formes de l’obésité., Presse méd, 55, 339

Bouchard, 1993, Genetic and nongenetic determinants of regional fat distribution., Endocr Rev, 14, 72, 10.1210/edrv-14-1-72

Larsson, 1984, Abdominal adipose tissue distribution, obesity and risk of cardiovascular disease and death: 13 year follow-up of participants in the study of men born in 1913., Br Med J (Clin Res Ed), 288, 1401, 10.1136/bmj.288.6428.1401

Lapidus, 1984, Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow-up of participants in the population study of women in Gothenburg, Sweden., Br Med J (Clin Res Ed), 289, 1257, 10.1136/bmj.289.6454.1257

49

Ducimetière, 1986, The pattern of subcutaneous fat distribution in middle-aged men and risk of coronary heart disease: The Paris Prospective Study., Int J Obes, 10, 229

Donahue, 1987, Central obesity and coronary heart disease in men., Lancet, 1, 821, 10.1016/S0140-6736(87)91605-9

Ohlson, 1985, The influence of body fat distribution on the incidence of diabetes mellitus—13.5 years of follow-up of the participants in the study of men born in 1913., Diabetes, 34, 1055, 10.2337/diab.34.10.1055

Kissebah, 1985, 115

Björntorp, 1984, Hazards in subgroups of human obesity., Eur J Clin Invest, 14, 239, 10.1111/j.1365-2362.1984.tb01174.x

Björntorp, 1985, Obesity and the risk of cardiovascular disease., Ann Clin Res, 17, 3

Fujioka, 1987, Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity., Metabolism, 36, 54, 10.1016/0026-0495(87)90063-1

Desprès, 1989, Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women., Diabetes, 38, 304, 10.2337/diab.38.3.304

Pouliot, 1992, Visceral obesity in men. Associations with glucose tolerance, plasma insulin and lipoprotein levels., Diabetes, 41, 826, 10.2337/diab.41.7.826

Park, 1991, Intra-abdominal fat is associated with decreased insulin sensitivity in healthy young men., Metabolism, 40, 600, 10.1016/0026-0495(91)90050-7

Märin, 1992, The morphology and metabolism of intraabdominal adipose tissue in men., Metabolism, 41, 1242, 10.1016/0026-0495(92)90016-4

Desprès, 1990, Regional distribution of body fat, plasma lipoproteins and cardiovascular disease., Arteriosclerosis, 10, 497, 10.1161/01.ATV.10.4.497

Desprès, 1991, Obesity and lipid metabolism: relevance of body fat distribution., Curr Opin Lipidol, 2, 5, 10.1097/00041433-199102000-00003

Desprès, 1991, Lipoprotein metabolism in visceral obesity., Int J Obes, 15, 45

Howard, 1987, Lipoprotein metabolism in diabetes mellitus., J Lipid Res, 28, 613, 10.1016/S0022-2275(20)38659-4

Laakso, 1990, Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degress of glucose tolerance., Arteriosclerosis, 10, 223, 10.1161/01.ATV.10.2.223

Desprès, 1996, Visceral obesity and dyslipidemia:contribution of insulin resistance and genetic susceptibility. In: Angel A, Anderson H, Bouchard C, Lau D, Leiter L, Mendelson R (eds) Progress in Obesity Research: Proceedings of the Seventh International Congress on Obesity (Toronto, Canada, August 20–25, 1994)., John Libbey & Company, London, vol, 7, 525

Desprès, 1992, Genetic aspects of susceptibility to obesity and related dyslipidemias., Mol Cell Biochem, 113, 151, 10.1007/BF00231535

Desprès, 1993, Abdominal obesity as an important component of insulin resistance syndrome., Nutrition, 9, 452

Abate, 1995, Relationships of generalized and regional adiposity to insulin sensitivity in men., J Clin Invest, 96, 88, 10.1172/JCI118083

Goodpaster, 1997, Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat., Diabetes, 46, 1579, 10.2337/diacare.46.10.1579

Smith, 1999, Visceral adipose tissue: a critical review of intervention strategies., Int J Obes, 23, 329, 10.1038/sj.ijo.0800834

Björntorp, 1991, Metabolic implications of body fat distribution., Diabetes Care, 14, 1132, 10.2337/diacare.14.12.1132

Björntorp, 1997, Endocrine abnormalities in obesity., Diabetes Rev, 5, 52

Abate, 1994, Estimation of adipose tissue mass by magnetic resonance imaging: validation against dissection in human cadavers., J Lipid Res, 35, 1490, 10.1016/S0022-2275(20)40090-2

Kissebah, 1997, Central obesity: measurement and metabolic effects., Diabetes Rev, 5, 8

Malina, 1988, 163

Pouliot, 1994, Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women., Am J Cardiol, 73, 460, 10.1016/0002-9149(94)90676-9

Bray, 1988, Treatment of obesity: an overview., Diabetes Metab Rev, 4, 653, 10.1002/dmr.5610040704

53

Ashwell, 1985, Obesity: new insight into the anthropometric classification of fat distribution shown by computed tomography., Br Med J (Clin Res Ed), 290, 1692, 10.1136/bmj.290.6483.1692

Ferland, 1989, Assessment of adipose tissue distribution by computed axial tomography in obese women: association with body density and anthropometric measurements., Br J Nutr, 61, 139, 10.1079/BJN19890104

Sjöström, 1996, The sagittal diameter is a valid marker of the visceral adipose tissue volume. In: Angel A, Anderson H, Bouchard C, Lau D, Leiter L, Mendelson R (eds) Progress in Obesity Research: Proceedings of the Seventh International Congress on Obesity (Toronto, Canada, August 20–25, 1994)., John Libbey & Company, London, vol, 7, 309

Seidell, 1988, Abdominal fat depots measured by computed tomography: effects of degree of obesity, sex, and age., Eur J Clin Nutr, 42, 805

Desprès, 1991, Estimation of deep abdominal adipose tissue accumulation from simple anthropometric measurements in men., Am J Clin Nutr, 54, 471, 10.1093/ajcn/54.3.471

Han, 1997, The influences of height and age on waist circumferences as an index of adiposity in adults., Int J Obes Relat Metab Disord, 21, 83, 10.1038/sj.ijo.0800371

Lean, 1995, Waist circumference as a measure for indicating need for weight management., Br Med J, 311, 158, 10.1136/bmj.311.6998.158

Han, 1997, Waist circumference reduction and cardiovascular benefits during weight reduction in women., Int J Obes Relat Metab Disord, 21, 127, 10.1038/sj.ijo.0800377

Dowling, 1993, Race-dependent health risks of upper body obesity., Diabetes, 42, 537, 10.2337/diab.42.4.537

Snehalatha, Metabolism, 46, 1220, 10.1016/S0026-0495(97)90221-3

Fujimoto, Obesity Res, 2, 364, 10.1002/j.1550-8528.1994.tb00076.x

McKeigue, 1996, 54

Larsson, 1992, Is abdominal body fat distribuition a major explanation for the sex difference in the incidence of myocardial infarction? The study of men born in 1913 and the study of women, Göteborg, Sweden., Am J Epidemiol, 135, 266, 10.1093/oxfordjournals.aje.a116280

Han, 1995, Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample., Br Med J, 311, 1401, 10.1136/bmj.311.7017.1401

Kvist, 1988, Total and visceral adipose-tissue volumes derived from measurements with computed tomography in adult men and women: predictive equations., Am J Clin Nutr, 48, 1351, 10.1093/ajcn/48.6.1351

Van der Kooy, 1993, Abdominal diameters as indicators of visceral fat: comparison between magnetic resonance imaging and anthropometry., Br J Nutr, 70, 47, 10.1079/BJN19930104

Busetto, 1992, Assessment of abdominal distribution in obese patients: anthropometry vs. computerized tomography., Int J Obes Relat Metab Disord, 16, 731

Seidell, John Libbey & Company, London, vol, 7, 305

Ross, 1993, Adipose tissue distribution measured by magnetic resonance imaging in obese women., Am J Clin Nutr, 57, 470, 10.1093/ajcn/57.4.470

Seidell, 1994, The sagittal waist diameter and mortality in men: The Baltimore Longitudinal Study on Aging., Int J Obes, 18, 61

Chowdhury, 1994, A multicompartment body composition technique based on computorized tomography., Int J Obes Relat Metab Disord, 18, 219

Sjöström, 1996, A multicompartment body composition technique based on computerized tomography. In: Angel A, Anderson H, Bouchard C, Lau D, Leiter L, Mendelson R (eds) Progress in Obesity Research: Proceedings of the Seventh International Congress on Obesity (Toronto, Canada, August 20–25, 1994)., John Libbey & Company, London, vol, 7, 321

Ross, 1992, Quantification of adipose tissue by MRI: relationship with anthropometric variables., J Appl Physiol, 72, 787, 10.1152/jappl.1992.72.2.787

Sjöström, 1986, Determination of total adipose tissue and body fat in women by computed tomography, 40K and tritium, Am J Physiol, 250, E736

Kvist, 1986, Adipose tissue volume determinations in women by computed tomography: technical considerations., Int J Obes, 10, 53

Borkan, 1982, Assessment of abdominal fat content by computed tomography., Am J Clin Nutr, 36, 172, 10.1093/ajcn/36.1.172

Tokunaga, 1983, A novel technique for determination of body fat by computed tomography., Int J Obes, 7, 437

Enzi, 1986, Subcutaneous and visceral fat distribution according to sex, age and overweight, evaluated by computed tomography., Am J Clin Nutr, 44, 739, 10.1093/ajcn/44.6.739

Chowdhury, 1993, CT-determined changes in adipose tissue distribution during a small weight reduction in obese males., Int J Obes Relat Metab Disord, 17, 685

Mayo-Smith, 1989, Body fat distribution measured with CT: correlations in healthy subjects, patients with anorexia nervosa and patients with Cushing’s syndrome., Radiology, 170, 515, 10.1148/radiology.170.2.2911678

Zamboni, 1996, Methodological and clinical aspects of subcutaneous fat distribution., In: Angel A, Anderson H, Bouchard C, Lau D, Leiter L, Mendelson R (eds) Progress in Obesity Research: Proceedings of the Seventh International Congress on Obesity (Toronto, Canada, August 20–25, 1994) John Libbey & Company, London, vol, 7, 145

Thaete, 1995, Reproducibility of computed tomography measurement of visceral adipose tissue area., Int J Obes, 19, 464

Desprès, 1993, Effects of diet and physical activity on adiposity and body fat distribution: implications for the prevention of cardiovascular disease., Nutr Res Rev, 6, 137, 10.1079/NRR19930010

Hunter, 1994, Intra-abdominal adipose tissue variables associated with risk of possessing elevated blood lipids and blood pressure., Obes Res, 2, 563, 10.1002/j.1550-8528.1994.tb00106.x

Williams, 1996, Intra-abdominal adipose tissue cut-points related to elevated cardiovascular risk in women., Int J Obes, 20, 613

Lemieux, 1996, A single threshold value of waist girth indentifies normal-weight and overweight subjects with excess visceral adipose tissue., Am J Clin Nutr, 65, 685, 10.1093/ajcn/64.5.685

Anderson, 1997, Visceral fat and cardiovascular risk factors in chinese NIDDM patients., Diabetes Care, 20, 1854, 10.2337/diacare.20.12.1854

Matsuzawa, 1996, Visceral fat accumulation and cardiovascular disease. In: Angel A, Anderson H, Bouchard C, Lau D, Leiter L, Mendelson R (eds) Progress in Obesity Research: Proceedings of the Seventh International Congress on Obesity (Toronto, Canada, August 20–25, 1994)., John Libbey & Company, London, vol, 7, 569

Saito, 1998

Lottenberg, 1998, Effect of fat distribution on pharmocokinetics of cortisol in obesity., Int J Clin Pharmacol Ther, 36, 501

Van der Kooy, 1993, Techniques for the measurement of visceral fat: a predicted guide., Int J Obes Relat Metab Disord, 17, 187

Sobol, 1991, Evaluation of a new magnetic resonance imaging method for quantitating adipose tissue areas., Int J Obes, 15, 589

Armellini, 1993, Total and intra-abdominal fat measurements by ultrasound and computerized tomography., Int J Obes, 17, 209

Tornaghi, 1994, Anthropometric or ultrasonic measurements in assessment of visceral fat? A comparative study., Int J Obes, 18, 771

Armellini, 1990, The contribution of sonography to the measurement of intra-abdominal fat., J Clin Ultrasound, 18, 563, 10.1002/jcu.1870180707

Radominski, 1998

Armellini, 1991, Sonography detection of small intra-abdominal fat variations., Int J Obes, 15, 847

Armellini, 1994, Measured and predicted total and visceral adipose tissue in women. Correlations with metabolic parameters., Int J Obes Relat Metab Disord, 18, 641

Borkan, 1983, Age changes in body composition revealed by computed tomography., J Gerontol, 38, 673, 10.1093/geronj/38.6.673

Fowler, 1991, Total and subcutaneous adipose tissue in women: the measurement of distribution and accurate prediction of quantity by using magnetic resonance imaging., Am J Clin Nutr, 54, 18, 10.1093/ajcn/54.1.18

579

Lemieux, 1994, Are gender differences in cardiovascular disease risk factors explained by the level of visceral adipose tissue?, Diabetologia, 37, 757, 10.1007/BF00404332

Lemieux, 1993, Sex differences in the relation of visceral adipose tissue accumulation to total body fatness., Am J Clin Nutr, 58, 463, 10.1093/ajcn/58.4.463

Couillard, 1998, Postprandial triglyceride response in visceral obesity in men., Diabetes, 47, 953, 10.2337/diabetes.47.6.953

Bouchard, 1990, The response to long-term overfeeding in identical twins., N Engl J Med, 322, 1477, 10.1056/NEJM199005243222101

Zamboni, 1993, Effect of weight loss on regional body fat distribution in premenopausal women., Am J Clin Nutr, 58, 29, 10.1093/ajcn/58.1.29

Kern, John Libbey& Company, London, vol, 7, 89

Sniderman, 1995, 19

Rebuffé-Scrive, 1989, Metabolism of adipose tissue in intraabdominal depots of non-obese men and women., Metabolism, 38, 453, 10.1016/0026-0495(89)90198-4

Rebuffé-Scrive, 1990, Metabolism of adipose tissue in intraabdominal depots in severely obese men and women., Metabolism, 39, 1021, 10.1016/0026-0495(90)90160-E

Bonadonna, 1997, Glucose and free fatty acid metabolism in human obesity. Relationships to insulin resistance., Diabetes Rev, 5, 21

Arner, 1991, Expression of lipoprotein lipase in different human subcutaneous adipose tissue regions., J Lipid Res, 32, 423, 10.1016/S0022-2275(20)42065-6

Kern, 1990, The effects of weight loss on the activity and expression of adipose-tissue lipoprotein lipase in very obese humans., N Engl J Med, 332, 1053, 10.1056/NEJM199004123221506

Fain, 1983, Adrenergic regulation of adipocyte metabolism., J Lipid Res, 24, 945, 10.1016/S0022-2275(20)37910-4

Lönnqvist, 1993, Evidence for a functional β3-adrenoceptor in man., Br J Pharmacol, 110, 929, 10.1111/j.1476-5381.1993.tb13902.x

Enocksson, 1995, Demonstration of an in vivo functional β3-adrenoceptor in man., J Clin Invest, 95, 2239, 10.1172/JCI117914

Hellmer, 1992, Mechanisms for differences in lipolysis between human subcutaneous and omental fat cells., J Clin Endocrinol Metab, 75, 15

Arner, 1990, β-Adrenoceptor expression in human fat cells from different regions., J Clin Invest, 86, 1595, 10.1172/JCI114880

Lönnqvist, 1995, A pathogenic role of visceral fat β3-adrenoreceptors in obesity., J Clin Invest, 95, 1109, 10.1172/JCI117758

Hoffstedt, 1996, The metabolic syndrome is related to β3-adrenoceptor sensitivity in visceral adipose tissue., Diabetologia, 39, 838, 10.1007/s001250050518

Landin, 1990, Increased insulin resistance and fat cell lipolysis in obese but not lean women with high waist/hip ratio., Eur J Clin Invest, 20, 530, 10.1111/j.1365-2362.1990.tb01922.x

Mauriège, 1995, Regional variation in adipose tissue metabolism of severely obese premenopausal women., J Lipid Res, 36, 672, 10.1016/S0022-2275(20)40053-7

Reynisdottir, 1994, Catecholamine resistance in fat cells in women with upper-body obesity due to β2-adrenoceptors., Diabetologia, 37, 428, 10.1007/BF00408482

Björntorp, 1990, “Portal” adipose tissue as a generator of risk factors for cardiovascular disease and diabetes., Arteriosclerosis, 10, 493, 10.1161/01.ATV.10.4.493

Lönnqvist, 1997, Sex differences in visceral fat lipolysis and metabolic complications of obesity., Arterioscler Thromb Vasc Biol, 17, 1472, 10.1161/01.ATV.17.7.1472

Rebuffé-Scrive, 1985, Glucocorticoid hormone binding to human adipose tissue., Eur J Clin Invest, 15, 267, 10.1111/j.1365-2362.1985.tb00182.x

De Pergola G, 1998

Elbers, 1997, Long-term testosterone administration increases visceral fat in female to male transsexuals., J Clin Endocrinol Metab, 82, 2044

Polderman, 1994, Induction of insulin resistance by androgens and estrogens., J Clin Endocrinol Metab, 79, 265

Haarbo, 1991, Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause., Metabolism, 40, 323, 10.1016/0026-0495(91)90037-W

Mizutani, 1994, Identification of estrogen receptor in human adipose tissue and adipocytes, J Clin Endocrinol Metab, 78, 950

Rebuffé-Scrive, 1990, Steroid hormone receptors in human adipose tissue., J Clin Endocrinol Metab, 71, 1215, 10.1210/jcem-71-5-1215

Arner, 1996, Receptors in human adipose tissue., In: Angel A, Anderson H, Bouchard C, Lau D, Leiter L, Mendelson R (eds) Progress in Obesity Research: Proceedings of the Seventh International Congress on Obesity (Toronto, Canada, August 20–25, 1994) John Libbey& Company, London, vol, 7, 27

Lafontan, 1993, Fat cell adrenergic receptors and the control of white and brown fat cell function., J Lipid Res, 34, 1057, 10.1016/S0022-2275(20)37695-1

Cronrath, 1988, Nuclear triiodothyronine receptor of human adipose tissue., Metabolism, 37, 196, 10.1016/S0026-0495(98)90018-X

Vikman, 1991, Different metabolic regulation by adenosine in omental and subcutaneous adipose tissue., Acta Physiol Scand, 142, 405, 10.1111/j.1748-1716.1991.tb09174.x

Larrouy, 1991, A-1 adenosine receptors in human fat cell: tissue distribution and regulation of radioligand binding., Eur J Pharmacol, 206, 139, 10.1016/0922-4106(91)90022-A

Richelsen, 1988, Prostagladin E 2, action and binding in human adipocytes: effects of sex, age, and obesity., Metabolism, 37, 268, 10.1016/0026-0495(88)90107-2

Pérusse, 1996, Familial aggregation of abdominal visceral fat: results from the Quebec Family Study., Metabolism, 46, 378, 10.1016/S0026-0495(96)90294-2

Pérusse, 1998, L’épidémiology génétique et la génétique moléculaire de l’obésité: les enseignements de l’étude des familles de Québec., Médecine/Sciences, 14, 914

Rice, 1997, Familial resemblance for abdominal visceral fat: the HERITAGE Family Study., Int J Obes, 21, 1024, 10.1038/sj.ijo.0800511

Bouchard, 1996, Major gene for abdominal visceral fat area in the Quebec Family Study., Int J Obes, 20, 420

Rice, 1997, Segregation analysis of abdominal visceral fat: the HERITAGE Family Study., Obes Res, 5, 417, 10.1002/j.1550-8528.1997.tb00664.x

Rice, 1993, Segregation analysis of fat mass and other body composition measures derived from underwater weighing., Am J Hum Genet, 52, 967

Rice, 1996, Familial clustering of abdominal visceral fat and total fat mass: The Quebec Family Study., Obes Res, 4, 253, 10.1002/j.1550-8528.1996.tb00543.x

Bouchard, 1994, The response to exercise with constant energy intake in identical twins., Obes Res, 2, 400, 10.1002/j.1550-8528.1994.tb00087.x

Chagnon, 1997, The human obesity gene map: the 1997 update., Obes Res, 6, 76, 10.1002/j.1550-8528.1998.tb00318.x

Bouchard, 1994, DNA sequence variation in the lipoprotein lipase (LPL) gene and obesity., FASEB J, 8, 923

Dériaz, 1994, DNA variation in the genes of the Na, K-adenosine triphosphatase and its relation with resting metabolic rate, respiratory quotient, and body fat., J Clin Invest, 93, 838, 10.1172/JCI117038

Widén, 1995, Association of a polymorphism in the β 3-adrenergic receptor gene with features of the insulin resistance syndrome in Finns., N Engl J Med, 333, 348, 10.1056/NEJM199508103330604

Clément, 1995, Genetic variation in the β3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity., N Engl J Med, 333, 352, 10.1056/NEJM199508103330605

Kim-Motoyama, 1997, A mutation of the β3-adrenergic receptor is associated with visceral obesity but decreased serum triglyceride., Diabetologia, 40, 469, 10.1007/s001250050702

Vohl, 1995, The lipoprotein lipase HindIII polymorphism modulates plasma triglyceride levels in visceral obesity., Arterioscler Thomb Vasc Biol, 5, 714, 10.1161/01.ATV.15.5.714

Pouliot, 1994, ApoB-100 gene EcoRI polimorphism. Relations to plasma lipoprotein changes associated with abdominal visceral obesity., Arterioscler Thromb, 14, 527, 10.1161/01.ATV.14.4.527

Buemann, 1997, Abdominal visceral fat is associated with a BclI restriction fragment length polymorphism at the glucocorticoid receptor gene locus., Obes Res, 5, 186, 10.1002/j.1550-8528.1997.tb00292.x

Klannemark, 1998, The putative role of the hormone-sensitive lipase gene in the pathogenesis of Type II diabetes mellitus and abdominal obesity., Diabetologia, 41, 1516, 10.1007/s001250051099

Ailhaud, 1998, L’adipocyte, cellule sécrétice et endocrine., Médecine/Sciences, 14, 858, 10.4267/10608/1157

Montague, 1998, Depot-related gene expression in human subcutaneous and omental adipocytes., Diabetes, 47, 1384, 10.2337/diabetes.47.9.1384

Fried, 1993, Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men., J Clin Invest, 92, 2191, 10.1172/JCI116821

Bolinder, 1983, Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis., Diabetes, 32, 117, 10.2337/diab.32.2.117

Maslowska, 1993, Regional differences in triacyglycerol synthesis in adipose tissue., J Lipid Res, 34, 219, 10.1016/S0022-2275(20)40749-7

Angel, 1996, Secretion of cholesteryl ester transfer protein by adipose tissue In: Angel A, Anderson H, Bouchard C, Lau D, Leiter L, Mendelson R (eds) Progress in Obesity Research: Proceedings of the Seventh International Congress on Obesity (Toronto, Canada, August 20–25, 1994)., John Libbey & Company, London, vol, 7, 13

Tall, 1993, Plasma cholesterely ester transfer protein., J Lipid Res, 34, 1255, 10.1016/S0022-2275(20)36957-1

Dullaart, 1994, Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism., Eur J Clin Invest, 24, 188, 10.1111/j.1365-2362.1994.tb00987.x

Arai, 1994, Increased plasma cholesteryl ester trasnfer protein in obese subjects. A possible mechanism for the reduction of serum HDL cholesterol levels in obesity., Arterioscler Thromb, 14, 1129, 10.1161/01.ATV.14.7.1129

Hayashibe, 1997, Increased plasma cholesteryl ester transfer activity in obese children., Atherosclerosis, 129, 53, 10.1016/S0021-9150(96)06014-5

Tsutsumi, 1992, Retinoids and retinoid-binding protein expression in rat adipocytes., J Biol Chem, 267, 1805, 10.1016/S0021-9258(18)46017-6

Okno, 1995, Regulation of adipocyte gene expression by retinoic acid and hormones: effects on the gene encoding cellular retinol-binding protein., J Lipid Res, 36, 137, 10.1016/S0022-2275(20)39762-5

Wei, 1997, Retinyl ester hydrolysis and retinol efflux from BFC-1 β adipocytes., J Biol Chem, 272, 14159, 10.1074/jbc.272.22.14159

Panahloo, 1996, Diminished fibrinolysis in diabetes mellitus and its implication for diabetic vascular disease 1996., Coron Artery Dis, 7, 723, 10.1097/00019501-199610000-00005

Alessi, 1997, Production of Plasminogen activator inhibitor-1 by human adipose tissue. Possible link between visceral fat accumulation and vascular disease., Diabetes, 46, 860, 10.2337/diab.46.5.860

Janand-Delenne, 1998, Visceral fat as a main determinant of plasminogen activator inhibitor-1 level in women., Int J Obes, 22, 312, 10.1038/sj.ijo.0800585

Alessi, 1988, Insulin stimulates the synthesis of plasminogen activator inhibitor-1 by human hepatocellular cell line Hep 62., Thromb Haemost, 60, 491, 10.1055/s-0038-1646997

Schneider, 1997, Dependence of augmentation of arterial endothelial cell expression of plasminogen activator inhibitor type 1 by insulin on soluble factors released from vascular smooth muscle cells., Circulation, 96, 2868, 10.1161/01.CIR.96.9.2868

Sironi, 1996, Plasminogen activator inhibitor type 1 synthesis and mRNA expression in Hep G2 cells are regulated by VLDL., Arterioscler Thromb Vasc Biol, 16, 89, 10.1161/01.ATV.16.1.89

Latron, 1991, Stimulating effect of oxidized low density lipoproteins on plasminogen activator inhibitor-1 synthesis by endothelial cells., Arterioscler Thromb, 11, 1821, 10.1161/01.ATV.11.6.1821

Grant, 1990, Short-term infusions of insulin, triacyglycerol and glucose do not cause acute increases in Plasminogen activator inhibitor–1 concentrations in man., Clin Sci, 79, 513, 10.1042/cs0790513

Schneider, 1996, Synergistic augmentation of expression of Plasminogen activator inhibitor type 1 induced by insulin, very low density lipoproteins and fatty acids., Coron Artery Dis, 7, 813, 10.1097/00019501-199611000-00004

Calles-Escandon, 1998, Induction of hyperinsulinemia combined with hyperglycemia and hypertriglyceridemia increases Plasminogen activator inhibitor-1 in blood of normal human subjects., Diabetes, 47, 290, 10.2337/diab.47.2.290

McGill, 1994, Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients., Diabetes, 43, 104, 10.2337/diab.43.1.104

Hamsten, 1987, Plasminogem activator inhibitor in plasma: risk factor for recurrent myocardial infarction., Lancet, 2, 3, 10.1016/S0140-6736(87)93050-9

Juhan-Vague, 1996, Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris., Circulation, 94, 2057, 10.1161/01.CIR.94.9.2057

Alessi

Morange

Levrant, 1987, 57

Cleland, 1985, Effects of aging and obesity on aromatase activity of human adipose cells., J Clin Endocrinol Metab, 38, 476

Bulun, 1994, Competitive reverse transcription-polymerase chain reaction analysis indicates that levels of aromatase cytochrome P450 transcripts in adipose tissue of buttocks, thighs and abdomen of women increase with advancing age., J Clin Endocrinol Metab, 78, 428

Kirschner, 1990, Androgen-estrogen metabolism in women with upper body vs. lower body obesity., J Clin Endocrinol Metab, 70, 473, 10.1210/jcem-70-2-473

Schneider, 1979, Increased estrogen production in obese men., J Clin Endocrinol Metab, 48, 633, 10.1210/jcem-48-4-633

Tchernof, 1995, Reduced testosterone and adrenal C19 steroid levels in obese men., Metabolism, 44, 513, 10.1016/0026-0495(95)90060-8

Martel, 1994, Widespread tissue distribution of steroid sulfatase, 3β-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3β-HSD), 17β-HSD, 5α-reductase, and aromatase activities in the rhesus monkey., Mol Cell Endocrinol, 104, 103, 10.1016/0303-7207(94)90056-6

Siiteri, 1987, Adipose tissue as as source of hormones., Am J Clin Nutr, 47, 277, 10.1093/ajcn/45.1.277

Anwar, 1998

Zhang, 1994, Positional cloning of the mouse obese gene and its human homologue., Nature, 72, 425, 10.1038/372425a0

Halaas, 1995, Weight-reducing effects of the plasma protein encoded by the obese gene., Science, 269, 543, 10.1126/science.7624777

Matson, 1996, Leptin and the regulation of body adiposity. A critical review., Diabetes Rev, 4, 488

Caro, 1996, Leptin: the tale of an obesity gene., Diabetes, 45, 1455, 10.2337/diab.45.11.1455

Maffei, 1995, Leptin levels in human and rodent: measurement of plasma leptin and obRNA in obese and weight-reduced subjects., Nat Med, 1, 1155, 10.1038/nm1195-1155

Montague, 1997, Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution., Diabetes, 46, 342, 10.2337/diab.46.3.342

Hamilton, 1995, Increved obese mRNA expression in omental fat cells from massively obese humans., Nat Med, 1, 953, 10.1038/nm0995-953

Tritos, 1997, Leptin:its role in obesity and beyond., Diabetologia, 40, 1371, 10.1007/s001250050838

Van Harmelen, 1998, Leptin secretion from subcutaneous and visceral adipose tissue in women., Diabetes, 47, 913, 10.2337/diabetes.47.6.913

Houseknecht, 1996, Evidence for leptin binding to proteins in serum of rodents and humans: modulation with obesity., Diabetes, 45, 1638, 10.2337/diab.45.11.1638

Kolaczynski, 1996, Response to leptin to short-term and prolonged overfeeding in humans., J Clin Endocrinol Metab, 81, 4162

Trayhurn, 1995, Effects of fasting and refeeding on ob gene expression in white adipose tissue of lean and obese mice., FEBS Lett, 368, 488, 10.1016/0014-5793(95)00719-P

Boden, 1996, Effect of fasting on serum leptin in normal human subjects., J Clin Endocrinol Metab, 81, 3419

Leroy, 1996, Expression of ob gene in adipose cells: regulation by insulin., J Biol Chem, 271, 2365, 10.1074/jbc.271.5.2365

Saladin, 1995, Transient increase in obese gene expression after food intake or insulin administration., Nature, 377, 527, 10.1038/377527a0

Halleux, 1998, Multihormonal control of ob gene expression and leptin secretion from cultured human visceral adipose tissue: increased responsiveness to glucocorticoids in obesity., J Clin Endocrinol Metab, 83, 902

Saad, 1998, Physiological insulinemia acutely modulates plasma leptin., Diabetes, 47, 544, 10.2337/diabetes.47.4.544

Elbers, 1997, Reversal of the sex difference in serum leptin levels upon cross-sex hormone administration in transsexuals., J Clin Endocrinol Metab, 82, 3267

Kirchgessner, 1997, Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes., J Clin Invest, 100, 2777, 10.1172/JCI119824

Mantzoros, 1997, Leptin concentrations in relation to body mass index and the tumor necrosis factor-α system in humans., J Clin Endocrinol Metab, 82, 3408

Kalra, 1999, Interacting appetite-regulating pathways in the hypothalamic regulation of body weight., Endocr Rev, 20, 68

Shimabukuro, 1997, Direct antidiabetic effect of leptin through triglyceride depletion of tissues., Proc Natl Acad Sci USA, 94, 4637, 10.1073/pnas.94.9.4637

Koyama, 1997, β-Cell function in normal rats made chronically hyperleptinemic by adenovirus-leptin gene therapy., Diabetes, 46, 1276, 10.2337/diab.46.8.1276

Seufert, 1999, Leptin suppression of insulin secretion and gene expression in human pancreatic islets: implications for the development of Adipogenic diabetes mellitus., J Clin Endocrinol Metab, 84, 670

Aubert, 1997, Regulation by glucocorticoids of angiotensinogen gene expression and secretion in adipose cells., Biochem J, 328, 701, 10.1042/bj3280701

Karlsson, 1998, Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II., J Clin Endocrinol Metab, 83, 3925

Serazin-Leroy, 1998

Hainault

Giacchetti, 1998

Kihara, 1998

Arita, 1998

Hotta, 1998

Kern, 1995, The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase., J Clin Invest, 95, 2111, 10.1172/JCI117899

Hotamisligil, 1995, Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance., J Clin Invest, 95, 2409, 10.1172/JCI117936

Dandona, 1996

Hotamisligil, 1998

Stephens, 1991, Transcriptional repression of the GLUT 4 and C/EBP genes in 3T3–L1 adipocytes by tumor necrosis factor-α., J Biol Chem, 266, 21839, 10.1016/S0021-9258(18)54714-1

Patton, 1986, Interferons and tumor necrosis factors have similar catabolic effects on 3T3–L1 cells., Proc Natl Acad Sci USA, 83, 8313, 10.1073/pnas.83.21.8313

Spiegelman, 1993, Through thick and thin: wasting, obesity, and TNF-α., Cell, 73, 625, 10.1016/0092-8674(93)90243-J

Jovinge, 1998, Evidence for a role of tumor necrosis factor-α in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease., Metabolism, 47, 113, 10.1016/S0026-0495(98)90203-7

Koistinen, 1998

Fried, 1999, 83

Spiegelman, 1998, PPAR-γ: adipogenic regulator and thiazolidinedione receptor., Diabetes, 47, 507, 10.2337/diabetes.47.4.507

Adams, 1997, Activators of peroxisome proliferator-activated receptorγ have depot-specific effects on human preadipocyte differentiation., J Clin Invest, 100, 3149, 10.1172/JCI119870

Lefebvre, 1998, Depot-specific differences in adipose tissue gene expression in lean and obese subjects., Diabetes, 47, 98, 10.2337/diab.47.1.98

Vidal-Puig, 1997, Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss and regulation by insulin and glucocorticoids., J Clin Invest, 99, 2416, 10.1172/JCI119424

Auboeuf, 1997, Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-α in humans. No alterations in adipose tissue of obese and NIDDM patients., Diabetes, 46, 1319, 10.2337/diab.46.8.1319

Vgontzas, 1997, Elevation of plasma cytokines in disorders of excessive daytime sleepeness: role of sleep disturbance and obesity., J Clin Endocrinol Metab, 82, 1313, 10.1210/jcem.82.5.3950

Fried, 1998, Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid., J Clin Endocrinol Metab, 83, 847

Päth, 1997, Interleukin-6 and the interleukin-6 receptor in the human adrenal gland:expression and effects on steroidogenesis., J Clin Endocrinol Metab, 82, 2343

Nonogaki, 1995, Interleukin-6 stimulates hepatic triglyceride secretion in rats., Endocrinology, 136, 2143, 10.1210/endo.136.5.7720663

Wabitsch, 1998

Kamay, 1996, Regulation of insulin-like growth factor-1 expression in mouse preadipocyte Ob1771., J Biol Chem, 271, 9883, 10.1074/jbc.271.17.9883

Ricquier, 1998, Les protéines découplantes mitochondriales., Médecine/Sciences, 14, 889, 10.4267/10608/1160

Patsch, 1998

Kogure, 1998

Oberkofler, 1998

Nordfors, 1998, Reduced gene expression of UCP-2 but not UCP-3 in skeletal muscle of human obese subjects., Diabetologia, 41, 935, 10.1007/s001250051010

Wilkinson, 1993, Biosynthesis of the vasoactive lipid monobutyrin., J Biol Chem, 268, 2844, 10.1016/S0021-9258(18)53850-3

Arner, 1998, Not all fat is alike., Lancet, 351, 1301, 10.1016/S0140-6736(05)79052-8

Martin, 1991, Effects of body fat distribution on regional lipolysis in obesity., J Clin Invest, 88, 609, 10.1172/JCI115345

Guo, 1999, Regional postprandial fatty acid metabolism in different obesity phenotypes., Diabetes, 48, 1586, 10.2337/diabetes.48.8.1586

Kissebah, 1989, Biology of regional fat distribution: relationship to non-insulin-dependent diabetes mellitus., Diabetes Metab Rev, 5, 83, 10.1002/dmr.5610050202

Lerario, 1997, Risk factors in obese women, with particular reference to visceral fat component., Diabete Metab, 23, 68

Brunzell, 1999

Svedberg, 1990, Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat adipocytes., Diabetes, 39, 570, 10.2337/diab.39.5.570

Ferrannini, 1983, Effect of fatty acids on glucose production and utilization in men., J Clin Invest, 72, 1737, 10.1172/JCI111133

Bevilacqua, 1987, Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects., Metabolism, 36, 502, 10.1016/0026-0495(87)90051-5

Boden, 1995, Role of fatty acids in the pathogenesis of insulin resistance and NIDDM., Diabetes, 45, 3

Wajchenberg, 1994, Syndrome X: a syndrome of insulin resistance. Epidemiological and clinical evidence., Diabetes Metab Rev, 10, 19, 10.1002/dmr.5610100103

Randle, 1965, The glucose-fatty acid cycle in obesity and maturity-onset diabetes mellitus., Ann NY Acad Sci, 131, 324, 10.1111/j.1749-6632.1965.tb34800.x

Kelley, 1996, The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transsport and phosphorylation in skeletal muscle., J Clin Invest, 97, 2705, 10.1172/JCI118724

Roden, 1996, Mechanism of free fatty acid-induced insulin resistance in humans., J Clin Invest, 97, 2859, 10.1172/JCI118742

Phillips, 1996, Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in non diabetic subjects., Metabolism, 45, 947, 10.1016/S0026-0495(96)90260-7

Unger, 1995, Lipotoxicity in the pathogenesis of obesity-dependent non-insulin dependent diabetes mellitus. Genetic and clinical implications., Diabetes, 44, 863, 10.2337/diab.44.8.863

Koyama, 1997, Tissue triglycerides, insulin resistance, and insulin production: implications for hyperinsulinemia in obesity, Am J Physiol, 273, E708

Santomauro, 1999, Overnight lowering of free fatty acids with acipimox improves insulin resistance and glucose tolerance in obese diabetic and non-diabetic subjects., Diabetes, 48, 1836, 10.2337/diabetes.48.9.1836

Boden, 1998, Acute lowering of plasma fatty acids lowers basal insulin secretion in diabetic and non-diabetic subjects., Diabetes, 47, 1609, 10.2337/diabetes.47.10.1609

Boden, J Clin Invest, 96, 1261, 10.1172/JCI118160

Dobbins, 1998, Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans., Diabetes, 4, 1613, 10.2337/diabetes.47.10.1613

Lillioja, 1987, Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man., J Clin Invest, 80, 415, 10.1172/JCI113088

Bonora, 1992, Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women., Diabetes, 41, 1151, 10.2337/diab.41.9.1151

Bonora

Solini, 1997, Protein metabolism in human obesity:Relationship with glucose and lipid metabolism and with visceral adpose tissue., J Clin Endocrinol Metab, 82, 2552

Banerji, 1997, 425

Bergman, 1979, Quantitative estimation of insulin sensitivity, Am J Physiol, 236, E667

Toffolo, 1995, Estimation of β-cell sensitivity from IVGTT C-peptide data. Knowledge of the kinetics avoids errors in modeling secretion., Diabetes, 44, 845, 10.2337/diab.44.7.845

Macor, 1997, Visceral adipose tissue impairs insulin secretion and insulin sensitivity but not energy expenditure in obesity., Metabolism, 46, 123, 10.1016/S0026-0495(97)90288-2

Peiris, 1986, Splanchnic insulin metabolism in obesity: influence of body fat distribution., J Clin Invest, 78, 1648, 10.1172/JCI112758

Hennes, 1997, Effects of free fatty acids and glucose on splanchnic insulin dynamics., Diabetes, 46, 57, 10.2337/diab.46.1.57

Ruderman, 1981, The “metabolically-obese”, normal–weight individual., Am J Clin Nutr, 34, 1617, 10.1093/ajcn/34.8.1617

Reaven, 1988, Banting Lecture: role of insulin resistance in human disease., Diabetes, 37, 1595, 10.2337/diab.37.12.1595

Caro, 1991, Insulin resistence in obese and non-obese men., J Clin Endocrinol Metab, 73, 691, 10.1210/jcem-73-4-691

Ruderman, 1998, The metabolicaly obese, normal-weight-weight individual revisited., Diabetes, 47, 699, 10.2337/diabetes.47.5.699

Hollenberg, 1987, Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance., Diabetes, 64, 1169

Zavaroni, 1989, Risk factors for coronary heart disease in healthy subjects with hyperinsulinemia and normal glucose tolerance., N Engl J Med, 320, 702, 10.1056/NEJM198903163201105

Bergstrom, 1990, Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men., Diabetes, 39, 104, 10.2337/diacare.39.1.104

Blair, 1984, Evidence for an increased risk for hypertension with centrally located body fat and the effect of race and sex on this risk., Am J Epidemiol, 119, 526, 10.1093/oxfordjournals.aje.a113770

Albu, 1997, Visceral fat and race-dependent health risks in obese nondiabetic premenopausal women., Diabetes, 46, 456, 10.2337/diab.46.3.456

Kohrt, 1993, Insulin resistence in aging is related to abdominal obesity., Diabetes, 42, 273, 10.2337/diab.42.2.273

Barker, 1993, Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidemia (Syndrome X): relation to reduced fetal growth., Diabetologia, 36, 62, 10.1007/BF00399095

Phillips, 1994, Thinness at birth and insulin resistance in adult life., Diabetologia, 37, 150, 10.1007/s001250050086

Valdez, 1994, Birthweight and adult health outcomes in a biethnic population in the USA., Diabetologia, 37, 624, 10.1007/BF00403383

Oseid, 1991, Insulin sensitivity, glucose effectiveness and body fat distribution pattern un nondiabetic offspring of patients with NIDDM., Diabetes Care, 14, 890, 10.2337/diacare.14.10.890

Coon, 1989, Effects of body composition and exercise capacity on glucose tolerance, insulin and lipoprotein lipids in healthy older men., Metabolism, 38, 1201, 10.1016/0026-0495(89)90160-1

Schneider, 1992, 1800

Nyholm, 1996, Insulin resistance in relatives of NIDDM patients: the role of physical fitness and muscle metabolism., Diabetologia, 39, 813, 10.1007/s001250050515

Perseghin, 1996, Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects., N Engl J Med, 335, 1357, 10.1056/NEJM199610313351804

Bouchard, 1993, Genetics of obesity., Annu Rev Nutr, 13, 337, 10.1146/annurev.nu.13.070193.002005

Eriksson, 1997, Exercise and the metabolic syndrome., Diabetologia, 40, 125, 10.1007/s001250050653

Desprès, 1994, Low-intensity endurance training, plasma lipoproteinas and the risk of coronary heart disease., J Intern Med, 236, 7, 10.1111/j.1365-2796.1994.tb01114.x

Oshida, 1989, Long-term mild jogging increases insulin action despite no influence on body mass index or VO2 max., J Appl Physiol, 66, 2206, 10.1152/jappl.1989.66.5.2206

Abe, 1996, Subcutaneous and visceral fat distribution and daily physical activity: comparison between young and middle aged women., Br J Sports Med, 30, 297, 10.1136/bjsm.30.4.297

Ross, 1997, Effects of diet-and exercise-induced weight loss on visceral adipose tissue in men and women., Sports Med, 24, 55, 10.2165/00007256-199724010-00005

Austin, 1990, Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk., Circulation, 82, 495, 10.1161/01.CIR.82.2.495

Tchernof, 1996, The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity and hyperinsulinemia in men., Diabetes Care, 19, 629, 10.2337/diacare.19.6.629

Lemieux, 1995, Do elevated levels of abdominal visceral adipose tissue contribute to age-related differences in plasma lipoprotein concentrations in men?, Atherosclerois, 118, 155, 10.1016/0021-9150(95)05603-T

Deprès, 1989, Adipose tissue distribution and plasma lipoprotein levels in obese women: importance of intra-abdominal fat., Arteriosclerosis, 9, 203, 10.1161/01.ATV.9.2.203

Lemieux, 1994, Are gender differences in cardiovascular disease risk factors explained by the level of visceral adipose tissue?, Diabetologia, 37, 747, 10.1007/BF00404332

N Engl J Med, 292, 35, 10.1056/NEJM197501022920108

Chandalia, 1995, Clinical Case Seminar. Postmortem findings in congenital generalized lipodystrophy., J Clin Endocrinol Metab, 80, 3077

Garg, 1992, Peculiar distribution of adipose tissue in patients with gongenital generalized lipodystrophy., J Clin Endocrinol Metab, 75, 358

Seip, 1996, 2

Wajchenberg, 1995, Estimation of body fat and lean tissue distribution by dual energy x-ray absorptiometry and abdominal body fat evaluation by computed tomography in Cushing’s disease., J Clin Endocrinol Metab, 80, 2791

Pan, 1997, Skeletal muscle triglyceride levels are inversely related to insulin action., Diabetes, 46, 983, 10.2337/diab.46.6.983

Simoneau, 1995, Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women., FASEB J, 9, 273, 10.1096/fasebj.9.2.7781930

Stein, 1997

Szczepaniak Babcock, 1999, Measurement of intracellular triglyceride stores by 1H spectroscopy: validation in vivo, Am J Physiol, 276, E977

Yost, 1995, Changes in skeletal muscle lipoprotein lipase activity in response to insulin/glucose in non-insulin-dependent diabetes mellitus., Metabolism, 44, 786, 10.1016/0026-0495(95)90193-0

Knudsen, 1995, Changes in lipolytic enzymes cluster with insulin resistance syndrome. Botnia Study Group., Diabetologia, 12, 563

McGarry, 1999, Review. Fatty acids, lipotoxicity and insulin secretion., Diabetologia, 42, 128, 10.1007/s001250051130

Kahn, 1999, Islet amyloid. A long-recognized but underappreciated pathological feature of type 2 diabetes., Diabetes, 48, 241, 10.2337/diabetes.48.2.241

Vigouroux, 1997, Genetic exclusion of 14 candidate genes in Lipoatropic diabetes using linkage analysis in 10 consanguineous families., J Clin Endocrinol Metab, 82, 3338

Garg, 1999, A gene for congenital generalized lipodystrophy to human chromosome 9q34., J Clin Endocrinol Metab, 84, 3390, 10.1210/jcem.84.9.6103

Märin, Metabolism, 41, 882, 10.1016/0026-0495(92)90171-6

Bujalska, Lancet, 349, 1210, 10.1016/S0140-6736(96)11222-8

Andrew, J Clin Endocrinol Metab, 83, 1806, 10.1210/jcem.83.5.4951

Pasquali, 1998

Pasquali, J Clin Endocrinol Metab, 77, 341

Moyer, Obes Res, 2, 255, 10.1002/j.1550-8528.1994.tb00055.x

Pasquali, Metabolism, 45, 351, 10.1016/S0026-0495(96)90290-5

Ljung, 1996, Inhibition of cortisol secretion by dexamethasone in relation to body fat distribution: a dose-response study., Obes Res, 4, 277, 10.1002/j.1550-8528.1996.tb00546.x

Wajchenberg, Horm Res, 45, 99, 10.1159/000184767

Seidell, Metabolism, 39, 897, 10.1016/0026-0495(90)90297-P

Haffner, 1993, Obesity, body fat distribution and sex hormones in men., Int J Obes, 17, 634

Haffner, 1988, The relationship of sex hormones to hyperinsulinemia and hyperglycemia., Metabolism, 7, 638

Copeland, 1990, The relationship between insulin-like growth factor 1, adiposity and aging., Metabolism, 39, 584, 10.1016/0026-0495(90)90022-5

Märin, 1992, The effects of testosterone treatment on body composition and metabolism in middle-aged obese men., Int J Obes, 16, 991

Kley, 1981, Evidence of hypogonadism in massively obese males due to decreased free testosterone., Horm Metab Res, 13, 639, 10.1055/s-2007-1019359

Giagulli, 1994, Pathogenesis of the decreased androgen levels in obese men., J Clin Endocrinol Metab, 79, 997

Leenen, 1994, Visceral fat accumulation in relation to sex hormones in obese men and women undergoing weight loss therapy., J Clin Endocrinol Metab, 78, 1515

Rissanen, 1994, Visceral adiposity, androgens and plasma lipids in obese men., Metabolism, 43, 1318, 10.1016/0026-0495(94)90229-1

Smith, 1996, The endocrinology of obesity., Endocrinol Metab Clin North Am, 25, 921, 10.1016/S0889-8529(05)70362-5

Vermeulen Kaufman, 1993, Attenuated luteinizing hormone (LH) pulse amplitude but normal LH pulse frequency and its relation to plasma androgens in hypogonadism of obese men., J Clin Endocrinol Metab, 76, 1140

Gooren, 1989, Androgens and estrogens in their negative feedback action in the hypothalamo-pituitary-testis axis: site of action and evidence of their interaction., J Steroid Biochem, 33, 757, 10.1016/0022-4731(89)90488-3

Spijkstra, 1988, Divergent effects of the antiandrogen tamoxifen and of estrogens on luteinizing hormone(LH) pulse frequency, but not on basal LH levels and LH pulse amplitude in men., J Clin Endocrinol Metab, 66, 355, 10.1210/jcem-66-2-355

Märin, 1993, Androgen treatment of abdominally obese men., Obes Res, 1, 245, 10.1002/j.1550-8528.1993.tb00618.x

Yang, 1995, Additive effects of growth hormone and testosterone on lipolysis in adipocytes of hypophysectomized rats., J Endocrinol, 147, 147, 10.1677/joe.0.1470147

Märin, 1995, Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens., J Clin Endocrinol Metab, 80, 239

Polderman, 1994, Induction of insulin resistance by androgens and estrogens., J Clin Endocrinol Metab, 79, 265

Glass, 1989, Endocrine aspects of obesity., Med Clin North Am, 73, 139, 10.1016/S0025-7125(16)30696-4

Veldhuis, 1991, Dual defects in pulsatile growth hormone secretion and clearence subserve the hyposomatotropism of obesity in man., J Clin Endocrinol Metab, 72, 51, 10.1210/jcem-72-1-51

Rasmussen, 1995, Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-1 levels in obese subjects., J Clin Endocrinol Metab, 80, 1407

Frystyk, 1995, 37

Rasmussen, 1994, The impact of obesity, fat distribution and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin and growth hormone., Metabolism, 43, 315, 10.1016/0026-0495(94)90099-X

Wabitsch, 1995, 45

Brummer, 1993, Adipose tissue and muscle volume determination by computed tomography in Acromegaly before and 1 year after adenomectomy., Eur J Clin Invest, 23, 199, 10.1111/j.1365-2362.1993.tb00762.x

Bengtsson, 1993, Treatment of adults with growth hormone deficiency with recombinant human growth., J Clin Endocrinol Metab, 76, 309

Jorgensen, 1996, Growth hormone vs. placebo teatment for one year in growth hormone deficient adults: increase in exercise capacity and normalization of body composition., Clin Endocrinol (Oxf), 45, 681, 10.1046/j.1365-2265.1996.8720883.x

Beauville, 1992, Effect of long-term rhGH administration in GH-deficient adults on fat cell epinephrine response, Am J Physiol, 263, E467

West, 1989, Regional changes in adipose tissue flow and metabolism in rats after a meal, Am J Physiol, 257, R711

Rebuffé-Scrive, 1991, Neuroregulation of adipose tissue: molecular and hormonal mechanisms., Int J Obes, 15, 83

Rebuffé-Scrive, 1989, Metabolism of mammary, abdominal and femoral adipocytes in women before and after menopause., Metabolism, 35, 792, 10.1016/0026-0495(86)90217-9

Rebuffé-Scrive, 1987, Regional adipose tissue metabolism in men and postmenopausal women., Int J Obes, 11, 347

Metzger, 1994, Gonadal steroid hormone regulation of the somatotropic axis during puberty in humans. Mechanisms of androgen and estrogen action., Trends Endocrinol Metab, 5, 290, 10.1016/1043-2760(94)P3204-K